Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,900
Closed -$398K 3713
2025
Q3
$398K Sell
5,900
-3,300
-36% -$219K ﹤0.01% 2817
2025
Q2
$599K Buy
9,200
+5,000
+119% +$300K ﹤0.01% 2469
2025
Q1
$259K Buy
+4,200
New +$278K ﹤0.01% 2696
2023
Q2
Sell
-16,900
Closed -$1.36M 2647
2023
Q1
$1.36M Buy
16,900
+2,600
+18% +$209K 0.02% 1005
2022
Q4
$1.07M Buy
14,300
+5,700
+66% +$406K 0.02% 1059
2022
Q3
$554K Buy
+8,600
New +$596K 0.01% 1324
2021
Q4
Sell
-8,400
Closed -$620K 2672
2021
Q3
$620K Buy
+8,400
New +$630K 0.01% 1512

Other funds holding HOLX

Paul Tudor Jones's HOLX Position: Q2 2026 in Review

Paul Tudor Jones sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,196,804 shares — an estimated $166M sold.

Paul Tudor Jones first reported a position in HOLX in Q3 2013 and held it in 26 quarters. The position peaked at $166M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Paul Tudor Jones reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 2,196,804 Hologic shares in Q2 2026, an estimated $166M.
  • Paul Tudor Jones first reported a position in Hologic in Q3 2013 and held it in 26 quarters.
  • Paul Tudor Jones's Hologic position peaked at $166M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.